187 related articles for article (PubMed ID: 9126213)
1. Pap smears. Still a reliable screening tool for cervical cancer.
Stack PS
Postgrad Med; 1997 Apr; 101(4):207-8, 211-4. PubMed ID: 9126213
[TBL] [Abstract][Full Text] [Related]
2. The current status of the Papanicolaou smear.
Shingleton HM; Patrick RL; Johnston WW; Smith RA
CA Cancer J Clin; 1995; 45(5):305-20. PubMed ID: 7656133
[TBL] [Abstract][Full Text] [Related]
3. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
Eltabbakh GH; Eltabbakh GD
J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
[TBL] [Abstract][Full Text] [Related]
4. Pap smear refined.
Oncology (Williston Park); 1997 Aug; 11(8):1125. PubMed ID: 9268975
[No Abstract] [Full Text] [Related]
5. The evolution of the Papanicolaou smear.
Tambouret RH
Clin Obstet Gynecol; 2013 Mar; 56(1):3-9. PubMed ID: 23314726
[TBL] [Abstract][Full Text] [Related]
6. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
[TBL] [Abstract][Full Text] [Related]
7. Pap smear intervals safe.
AIDS Patient Care STDS; 2000 Dec; 14(12):675. PubMed ID: 11119436
[No Abstract] [Full Text] [Related]
8. Criticism of the Pap Smear as a Diagnostic Tool in Cervical Cancer Screening.
Schneider V
Acta Cytol; 2017; 61(4-5):338-344. PubMed ID: 28693015
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer screening among women without a cervix.
Sirovich BE; Welch HG
JAMA; 2004 Jun; 291(24):2990-3. PubMed ID: 15213211
[TBL] [Abstract][Full Text] [Related]
10. Effect of the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) on the incidence of invasive cervical cancer.
Helfand M; O'Connor GT; Zimmer-Gembeck M; Beck JR
Med Care; 1992 Dec; 30(12):1067-82. PubMed ID: 1453813
[TBL] [Abstract][Full Text] [Related]
11. Update on the Papanicolaou smear: new issues for the 1990s.
Ollayos CW
Mil Med; 1997 Aug; 162(8):521-3. PubMed ID: 9271901
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
13. The Papanicolaou smear: its impact on the promotion of women's health.
Foulks MJ
J Obstet Gynecol Neonatal Nurs; 1998; 27(4):367-73. PubMed ID: 9684199
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening. Who needs a Pap test? How often?
Benedet JL; Murphy KJ
Postgrad Med; 1985 Dec; 78(8):69-71, 74-6, 78-9. PubMed ID: 4070103
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
[TBL] [Abstract][Full Text] [Related]
16. The danger of only using a Pap smear.
Vazquez E
Posit Aware; 1999; 10(3):23. PubMed ID: 11366762
[TBL] [Abstract][Full Text] [Related]
17. George Papanicolaou (1883-1962): Discoverer of the Pap smear.
Tan SY; Tatsumura Y
Singapore Med J; 2015 Oct; 56(10):586-7. PubMed ID: 26512152
[No Abstract] [Full Text] [Related]
18. [False negative PAP test? Cytopathologist as a member of expert group in case of late diagnosis of cervical cancer].
Dusková J
Cesk Patol; 2010 Jul; 46(3):62-4. PubMed ID: 20941959
[TBL] [Abstract][Full Text] [Related]
19. The Pap smear revisited. Controversies and recent developments.
Zuna RE
Postgrad Med; 1984 Nov; 76(6):36-40, 42-3, 46. PubMed ID: 6494079
[TBL] [Abstract][Full Text] [Related]
20. New tests for cervical cancer screening.
Nuovo J; Melnikow J; Howell LP
Am Fam Physician; 2001 Sep; 64(5):780-6. PubMed ID: 11563569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
